Moneycontrol
HomeNewsTrendsEntertainmentKabhi khushi, kabhie gham: That’s the story at the box office as Covid looms large over cinemas
Trending Topics

Kabhi khushi, kabhie gham: That’s the story at the box office as Covid looms large over cinemas

Just when things were looking up for the film business, uncertainty has started looming over cinemas due to rising number of Covid-19 cases, particularly in Maharashtra, which accounts for a quarter of the overall box office collections of Hindi films

March 29, 2021 / 13:55 IST
Story continues below Advertisement

It’s been a topsy-turvy ride for the film business this year. After staying shut for more than six months last year due to the coronavirus-induced lockdown, cinemas reopened to a dull response with little fresh content.

But exhibitors started 2021 on a positive note, when southern superstar Vijay’s Master released. Then came the Rajkumar Rai and Janhvi Kapoor-starrer Roohi, which instilled theatre owners with more hope.

Story continues below Advertisement

“We recorded 22-23 percent occupancy for Roohi in the first week. With Roohi’s release, occupancy levels went up from 5 to 7 percent to double digits after a long time. And even in the second week, occupancy levels were at similar levels for Roohi,” Rudra Prasad Daw, Business Head, SVF Cinemas, told Moneycontrol.

Other theatre chains also witnessed higher occupancy levels with Roohi’s release. “Roohi has resulted in a boost in occupancy levels, especially in the North Indian market. The first weekend of Roohi had close to pre-Covid levels of occupancy for us,” said a spokesperson for multiplex chain Cinepolis.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show